events rule
American Academy of Neurology - Rhonda Voskuhl, M.D. - Topline Phase II Trimesta Results for Relapsing-Remitting MS
Tuesday, April 29, 2014 - Wednesday, April 30, 2014

Rhonda Voskuhl, M.D., the lead investigator of the Phase II clinical trial evaluating the Company's oral estriol product candidate, Trimesta™, for the treatment of relapsing-remitting multiple sclerosis (MS), will present topline results at the American Academy of Neurology's (AAN) 66th Annual Meeting in Philadelphia. The abstract titled, A Combination Trial of Estriol Plus Glatiramer Acetate in Relapsing-Remitting Multiple Sclerosis, will be presented as part of the AAN Emerging Science program during two sessions, as follows:

MS and CNS Inflammatory Disease: Novel Therapeutics
Presentation: 003
Event Date: Tuesday, April 29, 2014
Presentation Time: 3:45 p.m. (ET)

Emerging Therapeutic Advances in Multiple Sclerosis
Presentation: 002
Event Date: Wednesday, April 30, 2014
Presentation Time: 5:35 p.m. (ET)

No webcast available.

Year End 2013 Investor Conference Call
Monday, March 31, 2014
10:00am EDT

Synthetic Biologics will hold an investor conference call on Monday, March 31, 2014, at 10:00 am EDT. Interested parties should call 1-877-870-4263 (U.S. toll free), 1-855-669-9657 (Canada toll free), or +1 412-317-0790 (International), fifteen minutes before the start of the call to register. Registered callers on the toll free line may ask to be placed in the queue for the Question & Answer Session. The call will also be webcast over the Internet at http://www.videonewswire.com/event.asp?id=98657. If you are unable to participate during the live conference call, the webcast will be available for replay at the same URL, http://www.videonewswire.com/event.asp?id=98657 for 30 days after the call.

26th Annual ROTH Conference
Tuesday, March 11, 2014
2:00pm PDT

Jeffrey Riley, Synthetic Biologics' CEO, is scheduled to present on Tuesday, March 11, 2014 at 2:00 p.m. (Pacific Time).

A live webcast of Synthetic Biologics' presentation can be accessed by logging onto the web at http://wsw.com/webcast/roth28/SYN. After the presentation, a replay will be archived and accessible for 30 days at the same website.

BIO CEO & Investor Conference 2014
Monday, February 10, 2014
10:00am EST

Jeffrey Riley, CEO, is scheduled to present at the BIO CEO & Investor Conference on Monday, February 10, 2014, at 10:00 a.m. (ET) in the Duke of Windsor room at the Waldorf Astoria in New York.

A live webcast of Synthetic Biologics' presentation may be accessed by logging onto the internet at http://www.veracast.com/webcasts/bio/ceoinvestor2014/98124275805.cfm. After the presentation, a replay will be archived and accessible for 30 days at the same website.

Biotech Showcase 2014 Conference
Wednesday, January 15, 2014
9:30am PST

Jeffrey Riley, CEO, will present at the Biotech Showcase 2014 Conference at 9:30 a.m. (PT) on Wednesday, January 15, 2014 in the Mission II Room at the Parc 55 Wyndham in San Francisco-Union Square.

A live webcast of Synthetic Biologics' presentation may be accessed by logging onto the internet at http://www.media-server.com/m/p/5hizpa44. After the presentation, a replay will be archived and accessible for 30 days at the same website.

OneMedForum San Francisco 2014 Conference
Tuesday, January 14, 2014
11:30am PST

Jeff Riley, Synthetic Biologics' CEO, will present at the OneMedForum San Francisco 2014 Conference being held at the Westin San Francisco on January 14, 2014.

A live webcast of Synthetic Biologics’ presentation will be available. URL: http://onemedplace.com/forum/webcast/. After the presentation, the archived replay will be available via OneMed Fourm at same same URL.

Archaea-Associated Diseases Conference Call with Mark Pimentel, MD, of Cedars-Sinai Medical Center
Monday, December 9, 2013
9:00am EST

Synthetic Biologics' Chief Executive Officer, Jeffrey Riley, will host a conference call on Monday, December 9th at 9:00 a.m. EST. During the call, Mark Pimentel, M.D., FRCP©, Director of the Gastrointestinal Motility Program at Cedars-Sinai, will provide an audio-visual presentation overview of the scientific basis and market opportunity of our new pathogen-specific approaches to archaea-associated diseases, such as, C-IBS, obesity and diabetes.

Interested parties should call 1-877-870-4263, (U.S. toll free), 1-855-669-9657 (Canada toll free), or +1-412-317-0790 (International), fifteen minutes before the start of the call to register. Registered callers on the toll free line may ask to be placed in the queue for the Question & Answer Session. The call will also be webcast over the Internet with a slide presentation at http://www.videonewswire.com/event.asp?id=97322.

If you are unable to participate during the live conference call, the webcast will be available for replay at the same URL, http://www.videonewswire.com/event.asp?id=97322.

2013 Therapeutic Area Partnerships Conference
Tuesday, November 19, 2013
4:00pm EST

SYN-004, Synthetic Biologics' product candidate for the prevention of C. difficile infections, was selected as a 2013 Top Project to Watch in the infectious disease area by Elsevier Business Intelligence.

Jeffrey Riley, CEO, will present at the 2013 Therapeutic Area Partnerships Conference on Tuesday, November 19, 2013 at 4:00pm (EST) at the Hyatt Regency in Boston.

Please note, this conference does not provide webcasting.

BIO-Europe 2013
Monday, November 4, 2013 - Wednesday, November 6, 2013

Synthetic Biologics' management will be participating at BIO-Europe 2013 in Vienna, Austria.
 

BioJapan 2013 World Business Forum
Wednesday, October 9, 2013
11:25am - 11:40am JST

Jeff Riley, Synthetic Biologics' CEO, will present at the BioJapan 2013 World Business Forum being held on October 9-11, 2013 in Yokohama, Japan. Mr. Riley is scheduled to present at 11:25 a.m. (Japan Standard Time) on Wednesday, October 9, 2013 at Pacifico Yokohama.

Webcasting is not available for this event.

First Global Life Sciences Conference - Warsaw, Poland
Monday, September 16, 2013
5:15am EDT

Jeff Riley, Synthetic Biologics' CEO, will present at the First Global Life Sciences Conference to be held on September 16-17, 2013 in Warsaw, Poland. Mr. Riley is scheduled to present at 11:15 a.m. (Central European Summer Time)/5:15 a.m. (Eastern Time) on Monday, September 16, 2013 at the Warsaw Stock Exchange.

A live webcast of Synthetic Biologics’ presentation will be available. URL: http://www.wdmcapital.com/en/strony/lsc/live_webcast.html

After the presentation, the archived replay will be available via at the following URL:http://www.wdmcapital.com/en/strony/lsc/live_webcast.html

Rodman & Renshaw 15th Annual Healthcare Conference
Monday, September 9, 2013
12:05pm EDT

Jeff Riley, Synthetic Biologics' CEO, will present at the Rodman & Renshaw 15th Annual Healthcare Conference being held at the Millennium Broadway Hotel in New York City on September 9, 2013.

A live webcast of Synthetic Biologics’ presentation will be available. URL: http://wsw.com/webcast/rrshq23/SYN

After the presentation, the archived replay will be available via at the following URL: http://wsw.com/webcast/rrshq23/SYN